The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.smaller Cos. Regulatory News (BSV)

Share Price Information for Br.smaller Cos. (BSV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 80.00
Bid: 78.50
Ask: 81.50
Change: 0.00 (0.00%)
Spread: 3.00 (3.822%)
Open: 80.00
High: 80.00
Low: 80.00
Prev. Close: 80.00
BSV Live PriceLast checked at -
British Smaller Companies VCT is an Investment Trust

To maximise Total Return and provide investors with an attractive long-term tax-free dividend yield while maintaining the Company's status as a venture capital trust.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

1st Quarter Results

13 Sep 2023 07:00

RNS Number : 2903M
British Smaller Companies VCT PLC
13 September 2023
 

British Smaller Companies VCT plc

Interim Management Statement

For the quarter ended 30 June 2023

British Smaller Companies VCT plc (the "Company") presents its interim management statement for the quarter ended 30 June 2023. The statement also includes relevant financial information between the end of the quarter and the date of this statement. A copy of this interim management statement can be found at www.bscfunds.com.

Overview

In the quarter to 30 June 2023, the Company's Net Asset Value per share return was unchanged at 83.7 pence. In comparison, the FTSE Small Cap Index fell by 0.4 per cent during the period. AIC data ranks the Company first across all generalist VCTs when considering a blended average performance ranking over 1, 3, 5, 7 and 10 years.

The Company's Total Return at 30 June 2023 was unchanged at 258.6 pence per ordinary share.

During the quarter, the Company invested £2.6 million into Workbuzz, an employee insights and engagement settlement platform. The Company also invested a further £0.8 million into Relative Insight.

The Company realised its investment in Ncam in April, generating initial proceeds of £1.4 million. There is the potential for additional receipts of up to £1.2 million depending on the achievement of certain milestones over the coming years, which would see the Company fully recover its investment; £0.3 million of deferred proceeds have been recognised at the period end.

Subsequent to the period end, the Company has made a further investment of £0.3 million into Elucidat.

Performance

The table below sets out movements in key metrics for the Company. 

 

 

31 March 2023

Increase in Value

Shares issued

Buyback of shares

Movement

In Period

30 June 2023

Net Assets (£m)

157.0

0.4

44.4

(0.4)

44.4

201.4

NAV per share (PPS)

83.7

0.2

(0.2)

-

-

83.7

Cumulative dividends paid (PPS)

174.9

-

-

-

-

174.9

Total Return (PPS)

258.6

0.2

(0.2)

-

-

258.6

Shares in issue

187,679,279

-

53,559,905

(451,965)

53,107,940

240,787,219

Cumulative dividends paid at 30 June 2023 were unchanged at 174.9 pence per ordinary share (31 March 2023: 174.9 pence per ordinary share).

The movements in NAV and NAV per ordinary share are set out in the table below:

 

 

£m

Pence per

ordinary share

NAV at 31 March 2023

157.0

83.7

Increase in portfolio value

0.6

0.3

Net operating costs

(0.2)

(0.1)

0.4

0.2

Issue/buy-back of shares*

44.0

(0.2)

Total Return in the period

44.4

-

NAV at 30 June 2023

 

201.4

 

83.7

 

* The allotment of shares from the 2022/23 fundraising reduced total return per ordinary share as the fundraising was priced at the last reported NAV at the time of the allotment of 82.8 pence per ordinary share, being the NAV as at 31 December 2022 of 87.3 pence per ordinary share, adjusted for the special interim dividend of 4.5 pence per ordinary share paid on 11 January 2023.

 

Post-period end, on 28 July 2023, a dividend of 2.0 pence per ordinary share for the year ending 31 March 2024 was paid, resulting in a corresponding reduction to the 30 June 2023 unaudited NAV, to 81.7 pence per ordinary share.

Dividends and shares in issue

On 4 April 2023, the Company allotted 53,559,905 shares following the close of its 2022/23 fundraising.

Under its standing buyback authority, on 26 June 2023 the Company purchased 451,965 shares at 80.02 pence at a cost of £0.36 million. These shares are held in treasury. 

Subsequent to the quarter end, on 28 July 2023 the Company issued 1,270,231 shares under the Company's Dividend Re-investment Scheme (DRIS) following the payment of the interim dividend, taking the number of shares in issue at that date to 242,057,450, with a further 22,459,730 shares held in treasury.

Net assets

Net assets at 30 June 2023 comprised the following:

£000

% of net assets

Unquoted investments at fair value

125,850

62.5

Listed investment funds

3,745

1.9

Cash and cash equivalents

69,854

34.7

Other net assets

1,993

0.9

Net assets

201,442

100.0

Investments

The investment portfolio at 30 June 2023 comprised:

Valuation

£000

Cumulative valuation as a % of net assets

Matillion

24,886

12.4%

Unbiased

10,511

17.6%

Displayplan

8,829

22.0%

Outpost

8,680

26.3%

Wooshii

6,981

29.7%

Elucidat

6,226

32.8%

Force24

4,758

35.2%

Vypr

4,159

37.2%

ACC Aviation

4,095

39.3%

Quality Clouds

4,032

41.3%

 

83,157

41.3%

Other investments

42,693

21.2%

Total investments

125,850

62.5%

Portfolio performance

Over the quarter to 30 June 2023, the aggregate unquoted portfolio valuation has increased by £0.8 million.

Fundraising

On 4 April 2023 the Company allotted shares from its fully subscribed 2022-23 share offer. £44.4 million was raised by the Company, resulting in the allotment of 53,559,905 ordinary shares.

On 2 August 2023, the Company announced its intention to launch a joint offer for subscription for the 2023-24 tax year later this year, alongside British Smaller Companies VCT2 plc. A prospectus with full details of the proposed Offer is expected to be published in mid-to-late September.

Outlook

Portfolio companies continue to show resilience in navigating a challenging macro environment, charting a path that balances continued growth with a move towards profitability. While rising interest rates will slow economic growth, a more capital constrained environment reduces competition and alternative funding sources, providing opportunities for further deployment of capital for the Company, in both new and existing portfolio companies. In this vein, the Company continues to see a healthy pipeline of opportunities in which to invest in fast growing British businesses.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

13 September 2023

For further information please contact:

David Hall YFM Private Equity Limited Tel: 0113 244 1000

Alex Collins Panmure Gordon (UK) Limited Tel: 0207 886 2767

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRFEALNDFAXDEEA
Date   Source Headline
7th Jul 201611:01 amRNSTransaction in Own Shares
17th Jun 201611:12 amRNSTransaction in Own Shares
17th Jun 20169:46 amRNSDividend Declaration
16th Jun 20164:05 pmRNSAnnual Financial Report
24th Mar 20163:33 pmRNSPurchase of Own Securities
11th Mar 201610:14 amRNSPayment of dividend and allotment of shares
25th Feb 20163:09 pmRNSDisclosure of Home Member State
24th Feb 201611:24 amRNSIssue of Equity and Close of Offer
9th Feb 201611:46 amRNSClose of Offer to New Subscriptions
2nd Feb 201610:00 amRNSThird Quarter Results and Offer for Subscription
15th Jan 20169:25 amRNSPayment of Interim Dividend and Issue of Shares
27th Nov 201512:33 pmRNSUnaudited interim results to 30 September 2015
1st Oct 20154:35 pmRNSTransaction in Own Shares
30th Sep 201512:09 pmRNSTransaction in Own Shares
7th Sep 201510:49 amRNSPayment of Special Dividend and Allotment of Share
14th Aug 201511:06 amRNSPurchase of Own Securities and Total Voting Rights
4th Aug 201511:51 amRNSPayment of Final Dividend and Allotment of Shares
29th Jul 20152:35 pmRNSResult of Annual General Meeting
29th Jul 201510:56 amRNSInterim Management Statement
19th Jun 201511:21 amRNSAnnual Financial Report
22nd Apr 20152:00 pmRNSIssue of Equity and Close of Offers
10th Apr 20153:46 pmRNSOffers for Subscription - Supplementary Prospectus
31st Mar 20154:39 pmRNSCompletion of new investment
31st Mar 201511:52 amRNSIssue of Equity Replacement
31st Mar 20157:00 amRNSIssue of Equity
24th Mar 20159:45 amRNSClose of Offers to New Applications
9th Mar 20154:15 pmRNSOver Allotment Facility
3rd Mar 201511:20 amRNSPayment of Interim Dividend & Allotment of Shares
2nd Mar 20154:29 pmRNSIssue of Equity
4th Feb 20152:58 pmRNSPurchase of Own Securities and Total Voting Rights
4th Feb 20152:32 pmRNSPurchase of Own Securities and Total Voting Rights
3rd Feb 20157:00 amRNSIssue of Equity
27th Jan 201511:09 amRNSInterim Management Statement to 31 December 2014
7th Jan 201510:40 amRNSPayment of Interim Dividend & Allotment of Shares
6th Jan 20153:34 pmRNSIssue of Equity
30th Dec 20147:00 amRNSTransaction in Own Shares
22nd Dec 20143:15 pmRNSRealisation of Investment
18th Dec 201410:00 amRNSCompletion of New Investment
3rd Dec 20143:19 pmRNSResult of General Meeting
2nd Dec 20143:28 pmRNSCompletion of New Investment
25th Nov 201411:35 amRNSInterim Results and Change of Company Secretary
27th Oct 20144:40 pmRNSCompletion of two new investments
20th Oct 20145:00 pmRNSPublication of Prospectus and Circular re: offers
17th Oct 20142:07 pmRNSFurther re Investment Portfolio as at 30 June 2014
23rd Sep 20142:33 pmRNSTransaction in Own Shares
1st Aug 201411:31 amRNSIssue of Equity
28th Jul 20143:22 pmRNSInterim Management Statement
22nd Jul 20141:10 pmRNSResult of AGM
27th Jun 20144:39 pmRNSTransaction in Own Shares
13th Jun 201410:01 amRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.